ArticleInternational journal of molecular medicine2024

NCAPD2 augments the tumorigenesis and progression of human liver cancer via the PI3K‑Akt‑mTOR signaling pathway.

Jiang-Xue Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.